BlackRock’s Firefly Neuroscience AIFF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Buy
187,168
+17,806
+11% +$31K ﹤0.01% 4783
2026
Q1
$369K Buy
169,362
+83,105
+96% +$103K ﹤0.01% 4605
2025
Q4
$75.5K Buy
86,257
+8,798
+11% +$16.4K ﹤0.01% 4965
2025
Q3
$225K Buy
77,459
+61,685
+391% +$175K ﹤0.01% 4660
2025
Q2
$44.6K Buy
+15,774
New +$50K ﹤0.01% 5009
2023
Q3
Sell
-117
Closed -$1.07K 5550
2023
Q2
$1.07K Sell
117
-1,146
-91% -$13K ﹤0.01% 5404
2023
Q1
$11K Buy
1,263
+40
+3% +$788 ﹤0.01% 5313
2022
Q4
$17.6K Buy
1,223
+27
+2% +$628 ﹤0.01% 5391
2022
Q3
$34K Sell
1,196
-33
-3% -$1.21K ﹤0.01% 5431
2022
Q2
$49K Buy
+1,229
New +$119K ﹤0.01% 5420

Other funds holding AIFF

BlackRock's AIFF Position: Q2 2026 in Review

BlackRock increased its Firefly Neuroscience (AIFF) stake by 11% in Q2 2026, buying an estimated $31K and bringing the position to 187,168 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #4783.

BlackRock first reported a position in AIFF in Q2 2022 and has held it in 10 quarters since. The position peaked at $369K in Q1 2026. 22 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.

  • BlackRock held 187,168 shares of Firefly Neuroscience worth $226K as of Q2 2026.
  • BlackRock bought 17,806 Firefly Neuroscience shares in Q2 2026, an estimated $31K.
  • Firefly Neuroscience made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4783 holding.
  • BlackRock first reported a position in Firefly Neuroscience in Q2 2022 and has held it in 10 quarters since.
  • BlackRock's Firefly Neuroscience position peaked at $369K in Q1 2026.
  • 22 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.